Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Hace 1 día · Liselotte Spettmann (1936–2024) — Begegnungen (1994) for organCarson Cooman, organPublished by Verlag Daniel Kunert in “Präludien und Fantasien (Orgelwerke, ...

    • 2 min
    • 8
    • Carson Cooman
  2. Hace 4 días · – Accomplished industry veteran brings deep strategic and operational expertise. DENVER--(BUSINESS WIRE)--May 7, 2024-- TriSalus Life Sciences ® Inc. (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, announced today the appointment of Liselotte Hyveled to its Board of Directors.

  3. Hace 4 días · DENVER, May 07, 2024 -- ( BUSINESS WIRE )-- TriSalus Life Sciences® Inc. (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment ...

  4. Hace 4 días · TriSalus Life Sciences® Inc. (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, announced today the appointment of Liselotte Hyveled to its Board of Directors.

  5. Hace 4 días · Rhea-AI Summary. TriSalus Life Sciences, a Nasdaq-listed oncology company, appointed Liselotte Hyveled to its Board of Directors. Hyveled, an industry veteran with over two decades of experience in pharmaceutical research and development, will contribute to TriSalus' vision of pioneering innovative treatments for liver and pancreatic cancers.

  6. Hace 4 días · TriSalus Life Sciences Inc. hat die Ernennung von Liselotte Hyveled in den Vorstand des Unternehmens bekannt gegeben. Liselotte Hyveled verfügt über mehr als zwei Jahrzehnte Erfahrung in der Förderung wissenschaftlicher Innovationen und der Weiterentwicklung von pharmazeutischen Pipelines durch exzellente Forschung und Entwicklung.

  7. Hace 4 días · TriSalus Life Sciences Inc. kondigde de benoeming aan van Liselotte Hyveled tot lid van de Raad van Bestuur. Mevrouw Hyveled heeft meer dan twintig jaar ervaring in het stimuleren van wetenschappelijke innovatie en het bevorderen van farmaceutische pijplijnen door middel van uitmuntend onderzoek en ontwikkeling.

  1. Otras búsquedas realizadas